Vaccine Market Size Worth USD 102.60 Billion in 2030

One of the key factors driving market revenue growth is the rise in infectious diseases in developing countries.

According to the most recent Emergen Research analysis, the global vaccine market reached USD 45.20 billion in 2021 and is expected to grow at a 9.7% CAGR during the forecast period. One of the key factors driving market revenue growth is the rise in infectious diseases in developing countries. The global rise in the prevalence of infectious diseases increases the burden of healthcare on countries and has an impact on their socioeconomic growth. Furthermore, the rise in the prevalence of infectious diseases like malaria, influenza, hepatitis, and HIV/AIDS is driving revenue growth. Furthermore, the emergence of drug-resistant microbial strains has hampered efforts to combat infectious diseases like pneumonia, cholera, malaria, and diarrhoea.

The potential for emerging infectious diseases to spread rapidly and cause global epidemics is a major concern as people come into closer contact with wild animals, travel much more frequently and over much greater distances than in the past, and live in more densely populated areas. Furthermore, diseases may emerge as a result of deliberate introduction into animal, human, or plant populations for terrorist purposes.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/290

Leading Players Profiled in the Report:

Pfizer, Inc., CSL Limited, GlaxoSmithKline Ltd., Merck & Co., Johnson & Johnson, Serum Institute of India Pvt., Ltd., AstraZeneca Plc., Sanofi Pasteur SA, Emergent BioSolutions, Inc., and Biological E Limited.

Some Key Highlights From the Report

The monovalent vaccine segment accounted for a significant revenue share in 2021. Monovalent vaccination is intended to immunize only one microbe and one antigen (for example, measles vaccine). This type of vaccination is preferred for inducing a high immunological response.

The pediatric segment revenue is expected to register a steady growth rate during the forecast period. Increasing attempts by companies to develop effective pediatric vaccinations for prevention of illness is expected to drive pediatric vaccine segment revenue growth.

The recombinant vaccine segment is expected to lead in terms of revenue contribution to the global market over the forecast period. Recombinant vaccines can be easily produced and have lesser risks as compared to other vaccines.

The Asia Pacific market is expected to register a considerably rapid growth rate in the global vaccine market over the forecast period owing to increased vaccine awareness and immunization initiatives. Rising cases of severe infectious diseases including novel coronavirus disease and growing demand for COVID-19 vaccines are driving market growth in this region.

Emergen Research has segmented the vaccine market based on type, patient type, disease, technology, and region:

Type Outlook (Revenue, USD Billion; 2019–2030)

Monovalent Vaccine

Multivalent Vaccine

Patient Type Outlook (Revenue, USD Billion; 2019–2030)

Adult

Pediatric

Disease Outlook (Revenue, USD Billion; 2019–2030)

Human Papillomavirus (HPV)

Pneumococcal Diseases

Hepatitis

Influenza

Diphtheria, Tetanus, Pertussis (DTP)

Polio

Covid-19

Herpes Zoster

Rotavirus

Varicella

Meningococcal Disease

Others

Technology Outlook (Revenue, USD Billion; 2019–2030)

Conjugate Vaccines

Inactivated & Subunit Vaccines

Live Attenuated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Viral Vector Vaccines

Covid-19 vaccines

Covaxin

Covidshield

Sputnik Light Vaccine

Corbevax Vaccine

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/290

Thank you for reading our report. To request a customization or for further inquiries, kindly get in touch with us. Our team will ensure the report is tailored meet to your needs.

Take a Related Report :-

3D printed metal market

plastic waste management market

Insulation market

Thermal Interface Materials Market

nanopharmaceutical market

Glass Fiber Market

Neurostimulator Market

digital biomarkers market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting

Read Press [email protected]  https://www.emergenresearch.com/press-release/global-vaccine-market

Latest Report|  Ceramic Fiber Market   Industrial Fabric Market

Trending Title    Aerospace Materials Market   Green Hydrogen Market

You may also like...

Leave a Reply

Your email address will not be published.